In addition, RICTOR ablation increased lapatinib-mediated cell death in HER2-amplified breast cancer cells, and similar results occurred with the combined use of lapatinib and PP242 (dual mTORC1/2 inhibition). Here, ERBB2 is linked to breast cancer.